You have 9 free searches left this month | for more free features.

tgr-1202

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Follicular Lymphoma Trial in New York (TGR-1202)

Terminated
  • Follicular Lymphoma
  • TGR-1202
  • New York, New York
    Columbia University Medical Center
Jun 28, 2021

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)

Terminated
  • Hodgkin Disease
  • Lymphoma, Non-hodgkin
  • New York, New York
    Columbia University Irving Medical Center - Center for Lymphoid
Jun 28, 2021

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Mantle Cell Lymphoma
  • Monterey, California
  • +5 more
Sep 6, 2021

Pancreatic Cancer, Colorectal Cancer, Rectal Cancer Trial in Nashville (TGR-1202, nab-paclitaxel + gemcitabine, Oxaliplatin +

Completed
  • Pancreatic Cancer
  • +5 more
  • TGR-1202
  • +3 more
  • Nashville, Tennessee
    TG Therapeutics Trial Site
Oct 1, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +3 more
  • Huntsville, Alabama
  • +153 more
Aug 19, 2022